# Sprint 100 — First Approved Promotion Path + Residual Watch

**Dates:** 2026-07-17 → 2026-07-21 (est. 4 days)  
**Lead:** producer / art-director + qa-lead  
**Program:** Post–S99 **Release residual** open — **S100 only** (not a multi-sprint Launch train)  
**Authority:**  
[`sprint-99-approved-review-queue-hygiene.md`](sprint-99-approved-review-queue-hygiene.md) ·  
[`s99-01-approved-review-queue-2026-07-16.md`](../qa/s99-01-approved-review-queue-2026-07-16.md) ·  
[`design/assets/approved-criteria-2026-07-14.md`](../../design/assets/approved-criteria-2026-07-14.md) ·  
[`production/qa/gauntlet-defect-registry.json`](../qa/gauntlet-defect-registry.json) ·  
S97 continuity ack (**i acknowledge** 2026-07-16) · stage **Release**

**Predecessors COMPLETE (do not reopen):**  
- **S94–S97** Release Continuity · **S98** pilot · **S99** review queue + residual hygiene  

**QA plan:** [`production/qa/qa-plan-sprint-100-approved-promotion-2026-07-16.md`](../qa/qa-plan-sprint-100-approved-promotion-2026-07-16.md)  
**Parallel kickoff:** [`production/agentic/sprint-100-parallel-kickoff-2026-07-16.md`](../agentic/sprint-100-parallel-kickoff-2026-07-16.md)

## Sprint Goal

Advance **Release residual quality** by executing the **human Approved review path** for at least one pilot asset (ASSET-006 or ASSET-021) under A1–A7 — promote to Approved **only** if a real human records `asset approved: ASSET-NNN` — and keep a **gauntlet residual watch** (closed-id retest; residuals stay watched unless fixed). Stage remains **Release**. **This is not Launch.**

## Capacity

- Total days: **4**  
- Buffer (20%): **0.75 day**  
- Available: **~3.25 days** across 2 parallel tracks (lean review mode)

## Tracks

| Track | Env | Story | Owner |
|-------|-----|-------|-------|
| Human Approved review execution | **Local** | S100-01 | producer / art-director |
| Gauntlet residual watch + retest | **Local** | S100-02 | qa-lead |
| Closeout smoke + floors cite | **Local** | S100-03 | producer |

## Must Have

| ID | Task | Acceptance |
|----|------|------------|
| S100-01 | Human Approved review execution | Session notes for **≥1** of ASSET-006/021 vs A1–A7; **either** real human phrase `asset approved: ASSET-NNN` + manifest Done→Approved for that id, **or** deferred/blocked note with **no invented phrase**; Approved may remain 0 |
| S100-02 | Residual watch + retest | Dual retest `GAUNTLET-SYN-T12-001` (optional MD-001); residuals **watched** unless real fix; hygiene note under `production/qa/` |
| S100-03 | Closeout | Smoke + sprint-status S100 flips; cite suite **≥1638/0f** last-gate family; stage **Release** |

## Should Have

| ID | Task | Acceptance |
|----|------|------------|
| S100-04 | GitNexus status note (S99-06 carry) | `node .gitnexus/run.cjs status` (or analyze if stale) cited in closeout |
| S100-05 | Second pilot review if capacity | Same rules as S100-01 for the other of 006/021 |

## Nice to Have

| ID | Task | Acceptance |
|----|------|------------|
| S100-06 | Expect discipline pointer | Confirm expect regen docs; regen only if oracle drift |

## Hard Gates

| Gate | Pass |
|------|------|
| Suite | Cite **≥1638/0f** last-gate (or RUN if C# touched) |
| Stage | **Release** throughout |
| Launch | **Not** advanced — commercial gate **out of scope** |
| Predecessors | S94–S99 COMPLETE; S97 ack preserved |
| Approved path | No auto-Approved; no invented human phrase |
| Residuals | Watched residuals not fake-closed |

## Carryover from Previous Sprint

| Item | Source | Disposition in S100 |
|------|--------|---------------------|
| A7 pending ASSET-006/021 | S99-01 queue | S100-01 human review |
| Approved count **0** | Manifest | May stay 0 |
| 5 residuals watched | S99-02 | S100-02 watch |
| S99-06 GitNexus note | backlog | S100-04 |
| Launch | Non-goal | Still not opened |

## Risks

| Risk | Probability | Impact | Mitigation |
|------|------------|--------|------------|
| Invented `asset approved:` | Med | Process debt | Human-only or deferred note |
| Treating as Launch prep | Low | Scope creep | Explicit non-goals |
| Fake-closing residuals | Med | QA blindness | Registry hygiene |

## Dependencies on External Factors

- Named art-director/producer for A7 human review  
- No Launch authorization  

## Definition of Done for this Sprint

- [x] All Must Have tasks completed  
- [x] QA plan exists (`production/qa/qa-plan-sprint-100-*.md`)  
- [x] Smoke closeout written  
- [x] Sprint-status.yaml S100 stories updated honestly  
- [x] Stage remains **Release**  
- [x] No Launch advance  
- [x] No invented Approved promotions  
- [x] S97–S99 remain closed (not rewritten incomplete)  

## Non-goals

- Launch stage advance / store submit / `commercial-launch-execution-gate-TBD`  
- Auto-Approved without human phrase  
- Full gauntlet ladder re-run unless C# lands  
- Reopening S94–S99 as incomplete  

---
*Created 2026-07-16 via /sprint-plan new (lean). Residual-grounded after S99. Stage **Release**. Not Launch.*

---
*S100 COMPLETE 2026-07-17 — A7 deferred (Approved=0); residual watch PASS. Stage **Release**.*
